| EPC0528 | Improving access and coverage of COVID-19 vaccination among people living with HIV in South-South Nigeria | E-poster | Epidemiology of COVID-19 |
| EPC0390 | Improvements in uptake of voluntary medical male circumcision in Malawi | E-poster | HIV prevention research |
| EPA0034 | Improvement of B cell responses by an HIV-1 amphiphilic polymer nanovaccine | E-poster | Host immune responses, vaccines and immunotherapies |
| EPB0252 | Improved virologic suppression in children living with HIV under the age of 5 in Tanzania after the initiation of a viremia clinic and pediatric dolutegravir | E-poster | Antiretroviral therapies and clinical issues in infants, children and adolescents |
| EPB0251 | Improved viral load suppression with transition to pediatric dolutegravir among ART-experienced children in Kenya and Cote d’Ivoire | E-poster | Antiretroviral therapies and clinical issues in infants, children and adolescents |
| EPE0861 | Improved treatment outcomes using family-centric care among PLHIV, Nagaland, India-2022 | E-poster | Implementation science and scale up of treatment |
| EPD0672 | Improved meaningful inclusion of female sex workers in injectable PrEP trials in Uganda | E-poster | Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts |
| EPE0784 | Implementing social networking strategy to reach men with mobile jobs: lessons learned from an HIV clinic in Malawi | E-poster | Implementation science and scale up of HIV testing |
| EPC0444 | Implementing social network strategy with fidelity facilitates high HIV testing yield among key populations | E-poster | Population-specific interventions for HIV prevention |
| LBEPX53 | Implementing pre-exposure prophylaxis through virtual platforms to reach hidden populations, vulnerable to HIV | E-poster | Implementation science and scale up of prevention |